F/m Emerald Life Sciences Innovation ETF Rating $25.15 -0.68 (-2.64%) As of 02/21/2025 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsTrends F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.91Holdings in LFSC have an aggregate rating of Moderate Buy based on 333 analyst ratings issued in the past year covering 30 companies (98.3% of the portfolio).LFSC Aggregate Price Target$25.09High Prediction$25.09Average Prediction$25.09Low Prediction$25.09Holdings in LFSC have an aggregate price target of $25.09 and a range of $25.09 to $25.09 covering 30 companies (98.3% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy10 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings6.38%INSMInsmed$81.06-3.0%4.0523 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage6.38%BBIOBridgeBio Pharma$36.85+0.1%4.8297 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews CoverageGap Up6.27%RDNTRadNet$59.47-5.1%3.9109 of 5 stars3.20$75.50 27.0%55.97%TVTXTravere Therapeutics$21.98-6.8%2.9586 of 5 stars2.93$27.77 26.3%14Earnings ReportAnalyst ForecastNews CoverageGap Down5.90%AKROAkero Therapeutics$51.84+2.5%4.4064 of 5 stars3.00$75.86 46.3%9Insider Trade5.53%BPMCBlueprint Medicines$92.25-2.2%2.9944 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade5.29%MMSIMerit Medical Systems$103.16-2.4%3.6393 of 5 stars3.00$109.80 6.4%11Positive News5.20%LIVNLivaNova$47.44-1.1%3.5845 of 5 stars3.00$69.17 45.8%7Upcoming Earnings4.60%WVEWave Life Sciences$11.13-1.8%4.3725 of 5 stars3.00$22.22 99.7%94.41%SLNOSoleno Therapeutics$46.13-2.7%4.5423 of 5 stars3.29$71.20 54.3%7News CoveragePositive News4.38%RAREUltragenyx Pharmaceutical$42.59-4.2%4.617 of 5 stars2.93$93.50 119.5%14Analyst Forecast4.07%COLLCollegium Pharmaceutical$29.13-2.1%3.9911 of 5 stars2.80$43.60 49.7%5News Coverage3.43%NEONeoGenomics$11.10-6.4%2.9491 of 5 stars2.80$19.80 78.4%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.43%SRPTSarepta Therapeutics$106.28-2.0%4.5118 of 5 stars2.87$176.77 66.3%23Upcoming Earnings3.20%TMDXTransMedics Group$71.95-4.6%3.6199 of 5 stars2.82$122.70 70.5%11News Coverage3.16%ITCIIntra-Cellular Therapies$128.60+0.0%3.916 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage3.10%BHVNBiohaven$36.90-7.2%3.4013 of 5 stars3.07$63.15 71.1%15Short Interest ↓Positive News2.49%ATECAlphatec$10.61-0.5%4.331 of 5 stars2.89$17.56 65.5%92.44%ACADACADIA Pharmaceuticals$19.95-1.7%2.5793 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓2.10%SYRESpyre Therapeutics$21.29-5.0%2.0632 of 5 stars3.13$54.83 157.6%8Analyst UpgradeNews Coverage1.67%UTHRUnited Therapeutics$361.10-1.7%4.3818 of 5 stars2.67$388.25 7.5%12Insider TradePositive News1.62%MDGLMadrigal Pharmaceuticals$336.23-4.2%3.2942 of 5 stars2.69$351.67 4.6%131.36%NVCRNovoCure$22.09+2.0%3.4783 of 5 stars2.67$32.67 47.9%6Upcoming EarningsNews Coverage1.33%GMEDGlobus Medical$80.43-4.4%4.8392 of 5 stars2.75$96.91 20.5%12Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading Volume1.07%ITGRInteger$129.96-3.9%2.5361 of 5 stars2.78$147.67 13.6%9Earnings ReportAnalyst ForecastNews CoveragePositive News1.07%WGSGeneDx$95.83-5.7%2.0371 of 5 stars2.50$72.33 -24.5%6Earnings ReportAnalyst ForecastNews Coverage0.92%OFIXOrthofix Medical$17.95-0.8%3.1108 of 5 stars2.80$23.33 30.0%5Upcoming Earnings0.79%IMVTImmunovant$21.26+4.0%2.7493 of 5 stars3.00$45.90 115.9%12Positive News0.43%SVRASavara$2.692.1216 of 5 stars2.86$9.86 266.4%7Positive News0.33%KROSKeros Therapeutics$11.01-0.2%3.437 of 5 stars2.57$52.56 377.6%14 This page (NASDAQ:LFSC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFSC Stock Alerts